… oral factor Xa inhibitor apixaban, started within 28 days after index stroke, is superior to
aspirin in preventing new … Primary endpoint was detection of new ischemic lesions in flair and …

… Factor Xa (fXa) inhibitors such as rivaroxaban and apixaban are becoming the anticoagulants
of … Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. …

… in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major
… . New oral anticoagulants: their advantages and disadvantages compared with vitamin K …

… research and has been determined by the New England Institutional Review Board to be …
to our interpretation that these two oral factor Xa inhibitors have similar effectiveness and safety…

… of CX3002 and apixaban on venous thrombosis in New Zealand … difference between CX3002
and apixaban on thrombosis of … measurement of direct factor Xa inhibitors: anti-Xa assay is …

… , several new oral agents that selectively target Factor Xa … of direct oral anticoagulants (DOACs),
rivaroxaban, apixaban, … of DOACs with factor Xa inhibitory effects, including apixaban, …

… ] Apixaban, another non-vitamin K antagonist, is a new oral … Addition of the novel oral
anti-coagulant apixaban to DAPT in … , [30] works by inhibiting factor Xa of the coagulation cascade, …

… We evaluated the impact of RIV, a direct oral factor Xa inhibitor, … the aggravation of
atherosclerosis induced by factor Xa. … by blocking the factor Xa–PAR2-mediated inhibition of …

… available calibrators of the various Xa inhibitors, and our apixaban and rivaroxaban assays
are calibrated … In emergent situations, expert opinion recommends antidote administration at …

… black box warning against the use of dabigatran, and oral factor Xa inhibitors are not …
generation of sufficient amounts of factor Xa to overwhelm apixaban. This concept is supported …